Complication risks in elderly patients undergoing percutaneous nephrolithotomy compared to younger populations
Older patients can safely undergo kidney stone surgery with careful care
This systematic review and meta-analysis of 45,603 patients investigated complication rates and stone-free rates in elderly versus non-elder…
New research shows older adults can safely have kidney stone surgery, though infection risks rise with age.
Enzalutamide plus ADT improves 5-year survival in metastatic hormone-sensitive prostate cancer
Prostate Cancer Drug Helps Men Live Years Longer, New Data Shows
This post hoc analysis of a phase 3 randomized controlled trial in 1150 patients with metastatic hormone-sensitive prostate cancer found tha…
Men with advanced prostate cancer who took enzalutamide lived years longer than those on standard treatment alone, according to five-year da…
Narrative review proposes AI framework for precision oncology task-architecture alignment
Cancer Doctors Get AI Teams That Talk to Each Other
This narrative review addresses the use of large language models, multimodal extensions, AI agents, and multi-agent systems in precision onc…
• AI agents now work together like human cancer care teams • Helps doctors make smarter treatment choices for patients • Still in testing, n…
Meta-analysis compares bladder preservation therapy vs cystectomy in elderly muscle-invasive bladder cancer
Bladder Preservation May Be Safe for Older Bladder Cancer Patients
This meta-analysis of 4888 elderly patients with muscle-invasive bladder cancer found no significant difference in 1-, 5-, and 10-year overa…
For older adults with aggressive bladder cancer, keeping the bladder may offer survival rates equal to surgery for the first five years, but…
Enzalutamide plus radium-223 extends survival in metastatic castration-resistant prostate cancer
Adding Radium-223 to enzalutamide extends life for advanced prostate cancer patients
This phase 3 randomized controlled trial in 446 patients with metastatic castration-resistant prostate cancer compared enzalutamide plus rad…
Adding a specific bone-targeting drug to standard treatment helps men with advanced prostate cancer live longer while managing side effects …
RIRS with TFLLT shows similar stone-free rates to PNL for 20-30 mm kidney stones in adults
Small kidney stones get cleared with less pain and blood loss now
This randomized prospective study compared Retrograde Intrarenal Surgery (RIRS) with Thulium Fiber Laser Lithotripsy (TFLLT) to Percutaneous…
A new laser technique clears large kidney stones with less pain and blood loss while keeping success rates high for patients
Systematic review and meta-analysis evaluates PRIMARY score on PSMA PET for prostate cancer detection
PRIMARY Score Finds Hidden Cancer With High Accuracy
This systematic review and meta-analysis of 1974 patients evaluated the diagnostic accuracy of the PRIMARY score on PSMA PET/CT or PET/MRI f…
A new scan reading tool catches most dangerous prostate cancers with high accuracy for men who have never had a biopsy.
Systematic review and meta-analysis compares micro-ultrasound and mpMRI guidance for prostate biopsy cancer detection
Micro-ultrasound guidance finds prostate cancer at same rate as MRI
This systematic review and meta-analysis evaluated clinically significant and insignificant prostate cancer detection rates between micro-ul…
A large analysis found micro-ultrasound and MRI guidance detect prostate cancer equally well during biopsy, offering a viable alternative fo…
Ultrasound-guided salvage brachytherapy with interstitial hyperthermia shows low toxicity in locally recurrent prostate cancer
New prostate cancer treatment shows low side effects after 5 years
This prospective phase 2 trial evaluated ultrasound-guided salvage brachytherapy with interstitial hyperthermia in 109 patients with locally…
A new treatment for recurrent prostate cancer kept 93% of patients alive at 5 years with very low serious side effects.
Online adaptive MRI-guided SBRT showed technical feasibility in intermediate-risk prostate cancer patients
New MRI-guided radiation technique works for most intermediate-risk prostate cancer patients
This Phase 2 non-randomized trial evaluated online adaptive magnetic resonance imaging (MRI)-guided stereotactic body radiation therapy in 5…
A new radiation method delivered the right dose to tumors in 85% of patients with intermediate-risk prostate cancer. This approach uses onli…
Phase II trial of CyberKnife SBRT and androgen deprivation therapy in unfavorable intermediate- to high-risk localized prostate cancer
Small trial shows CyberKnife radiation plus hormone therapy is well tolerated for high-risk prostate cancer
This Phase II trial evaluated CyberKnife-based SBRT with simultaneous integrated boost and androgen deprivation therapy in 20 patients with …
A small study of 20 men with high-risk prostate cancer found that CyberKnife radiation plus hormone therapy was well tolerated with low rate…
Patient-specific 3D printed kidney models improved comprehension and satisfaction compared to conventional 2D CT scans in PCNL patients
3D kidney models improve patient understanding before surgery
This randomized clinical study enrolled 40 individuals aged 18 to 80 planned for PCNL surgery.
A small study found that 3D printed kidney models significantly improved patient comprehension and satisfaction compared to standard 2D scan…